These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7903944)

  • 21. Age-dependent effects of dopamine receptor inactivation on cocaine-induced behaviors in male rats: Evidence of dorsal striatal D2 receptor supersensitivity.
    Crawford CA; Teran A; Ramirez GI; Katz CG; Mohd-Yusof A; Eaton SE; Real V; McDougall SA
    J Neurosci Res; 2019 Dec; 97(12):1546-1558. PubMed ID: 31304635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the effects of the dopamine D2 agonist quinelorane on tuberoinfundibular dopaminergic neuronal activity in male and female rats.
    Eaton MJ; Gopalan C; Kim E; Lookingland KJ; Moore KE
    Brain Res; 1993 Nov; 629(1):53-8. PubMed ID: 7904532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative effects of receptor inactivation, 17 beta-estradiol and pertussis toxin on dopaminergic inhibition of prolactin secretion in vitro.
    Meller E; Puza T; Diamond J; Lieu HD; Bohmaker K
    J Pharmacol Exp Ther; 1992 Nov; 263(2):462-9. PubMed ID: 1359107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The intrinsic activity of (-)-3-PPP vis-à-vis prolactin-suppressing dopamine D2 receptors in transfected GH4C1 cells is dependent on which secretagogue that is used to provoke prolactin release.
    Nilsson CL; Hellstrand M; Ekman A; Eriksson E
    Neuropharmacology; 1998; 37(2):233-42. PubMed ID: 9680248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Behavioral and radioligand binding evidence for irreversible dopamine receptor blockade by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Hamblin MW; Creese I
    Life Sci; 1983 May; 32(19):2247-55. PubMed ID: 6133202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential modification of striatal D1 dopamine receptors and effector moieties by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in vivo and in vitro.
    Hess EJ; Battaglia G; Norman AB; Creese I
    Mol Pharmacol; 1987 Jan; 31(1):50-7. PubMed ID: 3100940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopamine agonist-induced elevation of striatal acetylcholine: relationship between receptor occupancy and response in normal and denervated rat striatum.
    Enz A; Goldstein M; Meller E
    Mol Pharmacol; 1990 Apr; 37(4):560-5. PubMed ID: 1970116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intraventricular injection of neurotensin reduces dopamine D2 agonist binding in rat forebrain and intermediate lobe of the pituitary gland. Relationship to serum hormone levels and nerve terminal coexistence.
    von Euler G; Meister B; Hökfelt T; Eneroth P; Fuxe K
    Brain Res; 1990 Oct; 531(1-2):253-62. PubMed ID: 1981163
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Opposing roles for dopamine D1 and D2 receptors in the regulation of hypothalamic tuberoinfundibular dopamine neurons.
    Durham RA; Johnson JD; Eaton MJ; Moore KE; Lookingland KJ
    Eur J Pharmacol; 1998 Aug; 355(2-3):141-7. PubMed ID: 9760028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential sensitivity of [3H]7-OH-DPAT-labeled binding sites in rat brain to inactivation by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline.
    Levant B
    Brain Res; 1995 Nov; 698(1-2):146-54. PubMed ID: 8581473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The intrinsic activities of the partial dopamine receptor agonists (-)-3-PPP and TDHL on pituitary dopamine receptors are lower in female than in male rats.
    Carlsson M; Carlsson A; Eriksson E
    Eur J Pharmacol; 1987 Oct; 142(1):39-43. PubMed ID: 3691635
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of alkylating agents on dopamine D(3) receptors in rat brain: selective protection by dopamine.
    Zhang K; Weiss NT; Tarazi FI; Kula NS; Baldessarini RJ
    Brain Res; 1999 Nov; 847(1):32-7. PubMed ID: 10564733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Importance of D1 and D2 receptor stimulation for the induction and expression of cocaine-induced behavioral sensitization in preweanling rats.
    McDougall SA; Rudberg KN; Veliz A; Dhargalkar JM; Garcia AS; Romero LC; Gonzalez AE; Mohd-Yusof A; Crawford CA
    Behav Brain Res; 2017 May; 326():226-236. PubMed ID: 28284952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SDZ GLC 756, a novel octahydrobenzo[g]quinoline derivative exerts opposing effects on dopamine D1 and D2 receptors.
    Markstein R; Gull P; Rüdeberg C; Urwyler S; Jaton AL; Kalkman HO; Dixon AK; Hoyer D
    J Neural Transm (Vienna); 1996; 103(1-2):17-30. PubMed ID: 9026371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inverse agonism at dopamine D2 receptors. Haloperidol-induced prolactin release from GH4C1 cells transfected with the human D2 receptor is antagonized by R(-)-n-propylnorapomorphine, raclopride, and phenoxybenzamine.
    Nilsson CL; Ekman A; Hellstrand M; Eriksson E
    Neuropsychopharmacology; 1996 Jul; 15(1):53-61. PubMed ID: 8797192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-(p-isothiocyanatophenethyl)spiperone, a selective and irreversible antagonist of D2 dopamine receptors in brain.
    Xu SX; Hatada Y; Black LE; Creese I; Sibley DR
    J Pharmacol Exp Ther; 1991 May; 257(2):608-15. PubMed ID: 1674530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo irreversible blockade of cortical S2 serotonin receptors by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline: a technique for investigating S2 serotonin receptor recovery.
    Battaglia G; Norman AB; Newton PL; Creese I
    J Neurochem; 1986 Feb; 46(2):589-93. PubMed ID: 2934516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Behavioral effects of the reversible dopamine antagonist flupenthixol are not potentiated by N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline in the preweanling rat.
    McDougall SA; Bolanos CA
    Pharmacol Biochem Behav; 1995 Jan; 50(1):127-31. PubMed ID: 7700948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The partial dopamine receptor agonists (--)-3-PPP and transdihydrolisuride enhance prolactin secretion in female but not in male rats.
    Carlsson M; Eriksson E
    J Neural Transm; 1989; 77(2-3):211-6. PubMed ID: 2569498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of EEDQ on the synthesis and metabolism of dopamine in preweanling and adult rats.
    Crawford CA; McDougall SA; Bardo MT
    Neuropharmacology; 1994 Dec; 33(12):1559-65. PubMed ID: 7760979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.